Pretreatment level of CA 19-9 is a prognostic factor in advanced pancreatic cancer treated with chemotherapy

被引：0
|
作者：
Gansl, R. C. [1 ]
Reis, P. T. [1 ]
Tabacof, J. [1 ]
Simon, S. D. [1 ]
Machado, M. C. [1 ]
Borghesi, G. [1 ]
Saad, E. D. [1 ]
机构：
[1] Dendrix, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15637
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15637
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: Pretreatment levels or kinetics during chemotherapy?
    Boeck, Stefan
    Schulz, Christoph
    Stieber, Petra
    Holdenrieder, Stefan
    Weckbach, Sabine
    Heinemann, Volker
    ONKOLOGIE, 2007, 30 (1-2): : 39 - 42
  • [42] Rapid systematic review: The case for evaluating pretreatment CA 19-9 as a stratification factor in randomized clinical trials (RCT) in advanced pancreatic cancer (APC)
    Saad, E. D.
    Gansl, R. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] CA 19-9 as a predictor of response and survival in patients with pancreatic cancer treated with gemcitabine and cisplatin based chemotherapy.
    Patel, B
    Heilburn, L
    Khanna, A
    Venkatramanamoorthy, R
    Shields, A
    Philip, P
    Zalupski, M
    El-Rayes, B
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 355S - 355S
  • [44] Postresection CA 19-9 Value as a Prognostic Factor Response
    Seo, Yuji
    Kinsella, Timothy J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (01): : 107 - 107
  • [45] Postresection CA 19-9 Value as a Prognostic Factor Response
    Seo, Yuji
    Kinsella, Timothy J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (03): : 320 - 320
  • [46] Exploring the role of CA 19-9 level as a predictor of survival in patients with advanced pancreatic adenocarcinoma
    Bekaii-Saab, T.
    Majumber, A.
    Trolli, E.
    Thomas, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 391 - 391
  • [47] Prognostic relevance of CA 19-9, CEA, CRP, and LDH kinetics in patients treated with palliative second-line therapy for advanced pancreatic cancer
    Haas, Michael
    Laubender, Ruediger P.
    Stieber, Petra
    Holdenrieder, Stefan
    Bruns, Christiane J.
    Wilkowski, Ralf
    Mansmann, Ulrich
    Heinemann, Volker
    Boeck, Stefan
    TUMOR BIOLOGY, 2010, 31 (04) : 351 - 357
  • [48] Predictive and Prognostic Value of CA 19-9 in Resected Pancreatic Adenocarcinoma
    Joshua G. Barton
    John P. Bois
    Michael G. Sarr
    Christina M. Wood
    Rui Qin
    Kristine M. Thomsen
    Michael L. Kendrick
    Michael B. Farnell
    Journal of Gastrointestinal Surgery, 2009, 13 : 2050 - 2058
  • [49] Predictive and prognostic value of CA 19-9 in resected pancreatic adenocarcinoma
    Barton, Joshua G.
    Bois, John P.
    Wood, Christina M.
    Qin, Rui
    Kendrick, Michael L.
    Farnell, Michael B.
    GASTROENTEROLOGY, 2008, 134 (04) : A871 - A871
  • [50] Predictive and Prognostic Value of CA 19-9 in Resected Pancreatic Adenocarcinoma
    Barton, Joshua G.
    Bois, John P.
    Sarr, Michael G.
    Wood, Christina M.
    Qin, Rui
    Thomsen, Kristine M.
    Kendrick, Michael L.
    Farnell, Michael B.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2009, 13 (11) : 2050 - 2058
12345